Table 1.

Patient characteristics

100 mg q12 h (n = 21)	Mean	SD	Range	CV
Age (year)	53.6	17.9	19–80	33.4
Height (cm)	165.5	4.3	151–172	2.6
Weight (kg)	72.0	10.6	56–97	14.7
BMI (kg/m2)	26.1	3.7	21–37	14.3
eGFR (mL/min)	79.2	16.8	52–125	21.3
Urine samples (n)	8.9	2.8	5–17	31.9

50 mg q6 h (n = 17)	Mean	SD	Range	CV
Age (year)	62.1	14.5	25–84	23.3
Height (cm)	166	6.0	159–182	3.6
Weight (kg)	73.9	13.9	52–102	18.7
BMI (kg/m2)	26.8	4.9	19–37	18.3
eGFR (mL/min)	75.1	17.3	50–114	23.0
Urine samples (n)	8.4	3.2	2–15	37.8

Total group (n = 38)	Mean	SD	Range	CV
Age (year)	57.4	17.0	19–84	29.6
Height (cm)	165.7	5.1	151–182	3.1
Weight (kg)	72.8	12.2	52–102	16.7
BMI (kg/m2)	26.4	4.3	19–37	16.3
eGFR (mL/min)	77.4	17.2	50–125	22.2
Urine samples (n)	8.7	3	2–17	34.7

Shows the mean, standard deviation (SD), range, and confidence interval (CV) (%) per dose regimen and total patient group. Patients characteristics are comparable in both groups; age p = 0.13, height p = 0.76, weight p = 0.65, BMI p = 0.64, eGFR p = 0.48, and N urine samples p = 0.59